7.93
2.06%
0.16
시장 영업 전:
8.27
0.34
+4.29%
전일 마감가:
$7.77
열려 있는:
$7.67
하루 거래량:
106.27K
Relative Volume:
0.53
시가총액:
$396.12M
수익:
-
순이익/손실:
$-76.41M
주가수익비율:
-4.1302
EPS:
-1.92
순현금흐름:
$-64.56M
1주 성능:
+4.89%
1개월 성능:
-3.29%
6개월 성능:
-8.54%
1년 성능:
+2.85%
Aura Biosciences Inc Stock (AURA) Company Profile
명칭
Aura Biosciences Inc
전화
(617)500-8864
주소
80 GUEST STREET, BOSTON
AURA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
7.93 | 396.12M | 0 | -76.41M | -64.56M | -1.92 |
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-25 | 개시 | H.C. Wainwright | Buy |
2023-07-27 | 개시 | Scotiabank | Sector Outperform |
2023-04-17 | 재개 | BTIG Research | Buy |
2022-07-19 | 개시 | JMP Securities | Mkt Outperform |
Aura Biosciences Inc 주식(AURA)의 최신 뉴스
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock By Investing.com - Investing.com Australia
Aura Biosciences CEO Elisabet de los Pinos sells shares worth $122,381 - MSN
Aura Biosciences VP Amy Elazzouzi sells $7,679 in stock - Investing.com India
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat
Barclays PLC Acquires 43,897 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Cool Company Ltd. (NYSE:CLCO) Shares Purchased by Barclays PLC - Defense World
Barclays PLC Has $544,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of “Buy” from Brokerages - Defense World
(AURA) Trading Signals - Stock Traders Daily
Jane Street Group LLC Decreases Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Brokerages Set Innovative Industrial Properties, Inc. (NYSE:IIPR) Price Target at $104.50 - Defense World
Analysts Set Planet Labs PBC (NYSE:PL) Target Price at $4.33 - Defense World
Rush Street Interactive, Inc. (NYSE:RSI) Receives $12.43 Consensus PT from Analysts - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Consensus Price Target from Brokerages - Defense World
Talen Energy Corporation (NASDAQ:TLN) Receives $222.40 Average Target Price from Analysts - Defense World
Long Focus Capital Management, LLC Increases Stake in Aura Biosc - GuruFocus.com
Barclays PLC Buys 43,897 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket - Benzinga
(AURA) Trading Advice - Stock Traders Daily
Geode Capital Management LLC Raises Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
State Street Corp Increases Stake in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
AB Volvo (publ) (OTCMKTS:VOLVF) Stock Price Up 0.3% – Still a Buy? - Defense World
How to Take Advantage of moves in (AURA) - Stock Traders Daily
Franklin Resources Inc. Has $15.57 Million Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Wellington Management Group LLP Takes $1.04 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Holdings Lifted by Charles Schwab Investment Management Inc. - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Shares Sold by Fmr LLC - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Sees Significant Growth in Short Interest - MarketBeat
How the (AURA) price action is used to our Advantage - Stock Traders Daily
Learn to Evaluate (AURA) using the Charts - Stock Traders Daily
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in December - The Manila Times
Aura Biosciences CEO to Present at Evercore ISI HealthCONx Conference | AURA Stock News - StockTitan
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - MSN
When (AURA) Moves Investors should Listen - Stock Traders Daily
Aura Biosciences' chief medical officer sells $110,663 in stock By Investing.com - Investing.com Nigeria
Aura Biosciences' chief medical officer sells $110,663 in stock - Investing.com
HC Wainwright Forecasts Higher Earnings for Aura Biosciences - Defense World
HC Wainwright Has Bullish Forecast for AURA FY2024 Earnings - MarketBeat
Aura Biosciences’ (AURA) Buy Rating Reiterated at HC Wainwright - Defense World
What is Leerink Partnrs’ Estimate for AURA FY2024 Earnings? - Defense World
Leerink Partnrs Has Strong Forecast for AURA FY2024 Earnings - MarketBeat
Citadel Advisors LLC Reduces Stake in Aura Biosciences Inc - GuruFocus.com
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World
HC Wainwright Reaffirms Buy Rating for Aura Biosciences (NASDAQ:AURA) - MarketBeat
Aura Biosciences Reports Q3 Financial Results - TipRanks
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study - MSN
Aura Biosciences : Reports Third Quarter 2024 Financial Results and Business Highlights Form 8 K - Marketscreener.com
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Aura Biosciences Inc (AURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):